SPHS - Sophiris Bio, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 530.22M
Enterprise Value 330.72M
Trailing P/E N/A
Forward P/E 1-2.38
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-2.81

Trading Information

Stock Price History

Beta (3Y Monthly) 3.15
52-Week Change 3-60.47%
S&P500 52-Week Change 31.31%
52 Week High 33.4900
52 Week Low 30.7100
50-Day Moving Average 30.9994
200-Day Moving Average 30.9590

Share Statistics

Avg Vol (3 month) 3148.34k
Avg Vol (10 day) 379.45k
Shares Outstanding 530.22M
Float 30.16M
% Held by Insiders 10.85%
% Held by Institutions 17.94%
Shares Short (Jul 31, 2019) 42M
Short Ratio (Jul 31, 2019) 413.89
Short % of Float (Jul 31, 2019) 46.63%
Short % of Shares Outstanding (Jul 31, 2019) 46.62%
Shares Short (prior month Jun 28, 2019) 42.23M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 252/1
Last Split Date 3Aug 15, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-52.80%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -10.93M
Net Income Avi to Common (ttm)-1.88M
Diluted EPS (ttm)-0.0620
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)6.02M
Total Cash Per Share (mrq)0.2
Total Debt (mrq)6.52M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.41
Book Value Per Share (mrq)-0.08

Cash Flow Statement

Operating Cash Flow (ttm)-11.84M
Levered Free Cash Flow (ttm)-7.64M